CN114437932B - Microfluidic chip, system and using method of multi-placenta vascular anastomosis model - Google Patents
Microfluidic chip, system and using method of multi-placenta vascular anastomosis model Download PDFInfo
- Publication number
- CN114437932B CN114437932B CN202210134472.0A CN202210134472A CN114437932B CN 114437932 B CN114437932 B CN 114437932B CN 202210134472 A CN202210134472 A CN 202210134472A CN 114437932 B CN114437932 B CN 114437932B
- Authority
- CN
- China
- Prior art keywords
- fetal
- channel
- fluid
- fluid channel
- maternal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000003872 anastomosis Effects 0.000 title claims abstract description 68
- 230000002792 vascular Effects 0.000 title claims abstract description 57
- 238000000034 method Methods 0.000 title claims abstract description 24
- 239000012530 fluid Substances 0.000 claims abstract description 259
- 230000001605 fetal effect Effects 0.000 claims abstract description 133
- 230000008774 maternal effect Effects 0.000 claims abstract description 66
- 239000012528 membrane Substances 0.000 claims abstract description 61
- 210000002826 placenta Anatomy 0.000 claims abstract description 59
- 238000004088 simulation Methods 0.000 claims description 24
- 239000007788 liquid Substances 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 9
- 239000000126 substance Substances 0.000 claims description 8
- 238000005086 pumping Methods 0.000 claims description 6
- 230000004087 circulation Effects 0.000 claims description 4
- 230000006854 communication Effects 0.000 claims description 4
- 238000004891 communication Methods 0.000 claims description 4
- 230000037361 pathway Effects 0.000 claims 2
- 210000003754 fetus Anatomy 0.000 abstract description 57
- 230000017531 blood circulation Effects 0.000 abstract description 18
- 230000004888 barrier function Effects 0.000 abstract description 12
- 238000011160 research Methods 0.000 abstract description 11
- 210000004369 blood Anatomy 0.000 abstract description 5
- 239000008280 blood Substances 0.000 abstract description 5
- 230000002159 abnormal effect Effects 0.000 abstract description 4
- 230000007246 mechanism Effects 0.000 abstract description 3
- 238000006467 substitution reaction Methods 0.000 abstract description 2
- 230000001225 therapeutic effect Effects 0.000 abstract description 2
- 230000007310 pathophysiology Effects 0.000 abstract 1
- 210000004379 membrane Anatomy 0.000 description 50
- 210000004027 cell Anatomy 0.000 description 43
- 230000003169 placental effect Effects 0.000 description 25
- 230000000004 hemodynamic effect Effects 0.000 description 8
- 238000010586 diagram Methods 0.000 description 6
- 239000001963 growth medium Substances 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 230000008859 change Effects 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 210000002889 endothelial cell Anatomy 0.000 description 5
- 230000007176 multidirectional communication Effects 0.000 description 5
- 230000008289 pathophysiological mechanism Effects 0.000 description 5
- 210000002993 trophoblast Anatomy 0.000 description 5
- 208000034790 Twin pregnancy Diseases 0.000 description 4
- 239000004205 dimethyl polysiloxane Substances 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 210000004700 fetal blood Anatomy 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 4
- 230000035935 pregnancy Effects 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 208000037266 Selective intrauterine growth restriction Diseases 0.000 description 3
- 230000036770 blood supply Effects 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- -1 polytetrachlorethylene Polymers 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 2
- 208000002757 Fetofetal Transfusion Diseases 0.000 description 2
- 208000034702 Multiple pregnancies Diseases 0.000 description 2
- 208000035896 Twin-reversed arterial perfusion sequence Diseases 0.000 description 2
- 230000000712 assembly Effects 0.000 description 2
- 238000000429 assembly Methods 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 239000003613 bile acid Substances 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 210000001671 embryonic stem cell Anatomy 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 201000002161 intrahepatic cholestasis of pregnancy Diseases 0.000 description 2
- 210000005229 liver cell Anatomy 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 210000002569 neuron Anatomy 0.000 description 2
- 230000001991 pathophysiological effect Effects 0.000 description 2
- 230000009984 peri-natal effect Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- 201000002770 twin to twin transfusion syndrome Diseases 0.000 description 2
- 208000006332 Choriocarcinoma Diseases 0.000 description 1
- 208000001951 Fetal Death Diseases 0.000 description 1
- 206010055690 Foetal death Diseases 0.000 description 1
- 101150118536 HTR8 gene Proteins 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000002787 Pregnancy Complications Diseases 0.000 description 1
- 206010047163 Vasospasm Diseases 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000002457 bidirectional effect Effects 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 210000001043 capillary endothelial cell Anatomy 0.000 description 1
- 210000001136 chorion Anatomy 0.000 description 1
- 210000001728 clone cell Anatomy 0.000 description 1
- 230000001447 compensatory effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 238000009297 electrocoagulation Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 231100000479 fetal death Toxicity 0.000 description 1
- UQEAIHBTYFGYIE-UHFFFAOYSA-N hexamethyldisiloxane Polymers C[Si](C)(C)O[Si](C)(C)C UQEAIHBTYFGYIE-UHFFFAOYSA-N 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 238000010874 in vitro model Methods 0.000 description 1
- 238000011337 individualized treatment Methods 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000037419 placental anastomosis Effects 0.000 description 1
- 239000002985 plastic film Substances 0.000 description 1
- 229920006255 plastic film Polymers 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 208000012113 pregnancy disease Diseases 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 239000010902 straw Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 210000003606 umbilical vein Anatomy 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M23/00—Constructional details, e.g. recesses, hinges
- C12M23/02—Form or structure of the vessel
- C12M23/16—Microfluidic devices; Capillary tubes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M23/00—Constructional details, e.g. recesses, hinges
- C12M23/58—Reaction vessels connected in series or in parallel
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M29/00—Means for introduction, extraction or recirculation of materials, e.g. pumps
- C12M29/04—Filters; Permeable or porous membranes or plates, e.g. dialysis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M35/00—Means for application of stress for stimulating the growth of microorganisms or the generation of fermentation or metabolic products; Means for electroporation or cell fusion
- C12M35/08—Chemical, biochemical or biological means, e.g. plasma jet, co-culture
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Sustainable Development (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Clinical Laboratory Science (AREA)
- Dispersion Chemistry (AREA)
- Physiology (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Abstract
Description
技术领域technical field
本发明涉及微流控技术领域,特别是涉及一种多胎胎盘血管吻合模型的微流控芯片、系统及使用方法。The invention relates to the field of microfluidic technology, in particular to a microfluidic chip, a system and a use method of a multiple-fetal placenta vascular anastomosis model.
背景技术Background technique
双胎妊娠一直是围产医学和胎儿医学研究的重点,其自然妊娠过程及转归呈多样性,尤其是单绒毛膜双羊膜囊双胎,由于两个胎儿共用一个胎盘,胎盘之间存在1条以上的血管吻合,胎盘表浅部常存在双向血流的动脉-动脉、静脉-静脉吻合,胎盘深部的血管吻合往往呈单向血流,当缺乏表浅双向血流的补偿性血管吻合时会导致血流动力学失衡,故可出现较多且较严重的并发症,伴随围产儿发病率及死亡率的增加。研究双胎/多胎胎盘对双胎/多胎妊娠的早期诊断、个性化治疗的评估及预后等有重要意义。常规的体外和离体双胎/多胎模型多年来一直是研究正常和异常胎盘潜在机制的主流,出现了一些体外单胎模型,但是由于多胎/多胎之间的复杂性关系,并且体外细胞实验的静态性质与离体胎盘的快速衰老限制了它们生理相关性的研究,因此目前良好的双胎/多胎动物胎盘模型也仍未建立。Twin pregnancy has always been the focus of perinatal medicine and fetal medicine research. The natural pregnancy process and outcomes are diverse, especially monochorionic diamniotic twins. Because the two fetuses share a placenta, there is a 1 There are more than one vascular anastomosis in the superficial part of the placenta, and there are often arterial-arterial and venous-venous anastomoses with two-way blood flow in the superficial placenta, and vascular anastomoses in the deep placenta often show unidirectional blood flow. When there is no compensatory vascular anastomosis with superficial two-way blood flow It will lead to hemodynamic imbalance, so there may be more and more serious complications, accompanied by an increase in perinatal morbidity and mortality. Research on twin/multiple placenta is of great significance for early diagnosis of twin/multiple pregnancy, evaluation of individualized treatment and prognosis. Conventional in vitro and ex vivo twin/multiple pregnancy models have been the mainstream for studying the underlying mechanisms of normal and abnormal placentas for many years, and some in vitro single-fetal models have emerged. The static nature and rapid aging of isolated placentas limit the study of their physiological relevance, so good twin/multiple animal placenta models have not yet been established.
微流控是近年来备受关注的技术。通过精确控制和操控微尺度流体,尤指亚微米结构,将生物、化学、医学分析等基本操作集成到微米尺度的芯片上。流体在微流控芯片中展示了与宏观尺度不同的特殊性能,增加了体外模型的生物学复杂性和相关性。由于它在生物、化学、医学等领域的巨大潜力,已经发展成一个多学科交叉的崭新研究领域。目前,微流控器官芯片已开发了母胎界面免疫反应、胎盘摄取和运输、药物转运等方面的研究,但其应用局限于单胎母胎屏障,对于双胎/多胎胎盘母胎界面特殊结构及其潜在机制仍待探索。Microfluidics is a technology that has attracted much attention in recent years. By precisely controlling and manipulating micro-scale fluids, especially sub-micron structures, the basic operations of biology, chemistry, and medical analysis can be integrated on micron-scale chips. Fluids exhibit special properties in microfluidic chips that differ from those at the macroscale, increasing the biological complexity and relevance of in vitro models. Due to its great potential in biology, chemistry, medicine and other fields, it has developed into a new multidisciplinary research field. At present, microfluidic organ chips have been developed to study the immune response of the maternal-fetal interface, placental uptake and transportation, drug transport, etc., but its application is limited to the single-fetal maternal-fetal barrier. The mechanism is still to be explored.
发明内容Contents of the invention
本发明旨在至少解决现有技术中存在的技术问题,特别创新地提出了一种多胎胎盘血管吻合模型的微流控芯片、系统及使用方法。The present invention aims at at least solving the technical problems existing in the prior art, and particularly innovatively proposes a microfluidic chip, system and application method of a multi-fetal placenta vascular anastomosis model.
为了实现本发明的上述目的,根据本发明的第一个方面,本发明提供了一种多胎胎盘血管吻合模型的微流控芯片,包括芯片本体,所述芯片本体上设有母体流体通道以及两个或两个以上的胎儿流体通道,所述母体流体通道与胎儿流体通道之间设有多孔膜,所述胎儿流体通道之间设有可连通或断开的连接通道。In order to achieve the above object of the present invention, according to the first aspect of the present invention, the present invention provides a microfluidic chip for a multi-fetal placental vascular anastomosis model, including a chip body, and the chip body is provided with a maternal fluid channel and two There are one or more fetal fluid channels, a porous membrane is provided between the maternal fluid channel and the fetal fluid channel, and a connecting channel that can be connected or disconnected is provided between the fetal fluid channels.
上述技术方案:通过多孔膜实现母体与胎儿的流体和物质交换;通过连接通道模拟胎儿之间的胎盘浅表的双向血管吻合以及胎盘深部的单向血管吻合。通过微流控芯片对双胞胎或三胞胎等多胞胎胎盘结构进行准确、完整地微型化重构,可以模拟两种不同的绒毛膜性双胞胎胎盘的微结构,能为当前双胞胎/多胞胎的母胎屏障的研究及双胞胎/多胞胎特殊并发症的潜在病理生理机制研究提供代替模型;可允许代表同一母体的两个胎儿的两种循环在同一模型上培养以模拟双胞胎同一母体宫内环境,允许两种类型的胎盘结构在同一装置中培养以形成对照;可以模拟生理流动条件以实现双胞胎两胎儿与母体的血液对流运动,同一模型中的两胎儿之间的血液对流和/或单向流动;可以改变流动条件以模拟绒毛间隙和胎儿毛细血管的异常血液流动环境及施予治疗措施前后的变化。The above-mentioned technical solution: the fluid and material exchange between the mother and the fetus is realized through the porous membrane; the superficial two-way vascular anastomosis of the placenta and the one-way vascular anastomosis of the deep placenta between the fetuses are simulated through the connecting channel. Accurately and completely miniaturized reconstruction of the placenta structure of twins or triplets through the microfluidic chip can simulate the microstructure of two different chorionic twin placenta, which can be used for the current twin/multiple birth Provides a surrogate model for the study of the maternal-fetal barrier and the potential pathophysiological mechanisms of twin/multiple birth-specific complications; allows two circulations representing two fetuses of the same mother to be cultured on the same model to simulate the intrauterine environment of twins , allowing two types of placental structures to be cultured in the same device for comparison; physiological flow conditions can be simulated to achieve convective blood movement between twin fetuses and mother, convective blood flow between two fetuses in the same model and/or unidirectional Flow; the flow conditions can be changed to simulate the abnormal blood flow environment of the villi space and fetal capillaries and the changes before and after the application of therapeutic measures.
在一种优选实施方式中,所述连接通道包括使胎儿流体通道间双向或多向互通的第一连接通道。In a preferred embodiment, the connecting channel includes a first connecting channel for two-way or multi-directional communication between fetal fluid channels.
上述技术方案:通过第一连接通道准确模拟双胎/多胎胎盘浅表的双向(任意两个胎儿之间的)或多向(两个以上胎儿之间的)血管吻合情况。The above technical solution: Accurately simulate the two-way (between any two fetuses) or multi-way (between two or more fetuses) vascular anastomosis of superficial twin/multiple placenta through the first connection channel.
在一种优选实施方式中,所述第一连接通道上设有第一阀门组件。In a preferred embodiment, the first connecting channel is provided with a first valve assembly.
上述技术方案:便于控制第一连接通道的接通或断开,以便适配各种待模拟的病例。The above technical solution: it is convenient to control the connection or disconnection of the first connection channel, so as to adapt to various cases to be simulated.
在一种优选实施方式中,所述连接通道包括与胎儿流体通道连接的仅允许流体单向流通的第二连接通道。In a preferred embodiment, the connecting channel includes a second connecting channel that is connected to the fetal fluid channel and only allows fluid to flow in one direction.
上述技术方案:通过第二连接通道准确模拟胎盘深度的单向血管吻合情况。The above technical solution: accurately simulate the unidirectional anastomosis of the placenta depth through the second connection channel.
在一种优选实施方式中,两个胎儿流体通道之间设有一条或两条流通方向相反的第二连接通道。In a preferred embodiment, one or two second connecting channels with opposite flow directions are provided between the two fetal fluid channels.
上述技术方案:通过两条流通方向相反的第二连接通道能够准确模拟双胎/多胎中两个胎儿之间胎盘深部的动脉-动脉/静脉-静脉两种单向血管吻合。仅通过一条第二连接通道模拟两个胎儿之间胎盘深部的动脉-动脉/静脉-静脉两种单向血管吻合综合作用后的流体流通情况,在满足单向血管吻合实验效果的同时简化了芯片结构。The above-mentioned technical solution: the arterial-artery/vein-vein two-way one-way vascular anastomosis between two fetuses in twin/multiple fetuses can be accurately simulated through the second connecting channels with opposite flow directions. Only one second connection channel is used to simulate the fluid flow after the comprehensive effect of the arterial-artery/vein-vein two-way vascular anastomosis in the deep part of the placenta between the two fetuses, which simplifies the chip while satisfying the experimental effect of the one-way vascular anastomosis structure.
在一种优选实施方式中,所述第二连接通道上设有第二阀门组件。In a preferred embodiment, the second connecting channel is provided with a second valve assembly.
上述技术方案:便于控制第二连接通道的接通或断开,以便适配各种待模拟的病例。The above technical solution: it is convenient to control the connection or disconnection of the second connection channel, so as to adapt to various cases to be simulated.
在一种优选实施方式中,所述第二连接通道的第一端与胎儿流体通道连接,所述第二连接通道的第二端设有输入连接口。In a preferred embodiment, the first end of the second connection channel is connected to the fetal fluid channel, and the second end of the second connection channel is provided with an input connection port.
上述技术方案:在保证实验效果的同时,进一步简化了芯片结构,并且更易操作和实施。The above technical solution: while ensuring the experimental effect, further simplifies the chip structure, and is easier to operate and implement.
在一种优选实施方式中,所述胎儿流体通道上设有细胞池。In a preferred embodiment, the fetal fluid channel is provided with a cell pool.
上述技术方案:细胞池用于附着胎儿组织细胞,将胎儿部分组织代谢与母胎屏障动态变化联系,有利于进一步模拟母胎病理生理状态。The above technical solution: the cell pool is used for attaching fetal tissue cells, and links the metabolism of some fetal tissues with the dynamic changes of the maternal-fetal barrier, which is conducive to further simulating the pathophysiological state of the maternal-fetal.
在一种优选实施方式中,全部或部分胎儿流体通道位于所述芯片本体的第一侧,所述母体流体通道位于所述芯片本体的第二侧。In a preferred embodiment, all or part of the fetal fluid channel is located on the first side of the chip body, and the maternal fluid channel is located on the second side of the chip body.
上述技术方案:将胎儿流体通道与母体流体通道分别设于芯片本体的上下两侧,有利于减小芯片体积,实现微型化。The above technical solution: the fetal fluid channel and the maternal fluid channel are respectively arranged on the upper and lower sides of the chip body, which is conducive to reducing the volume of the chip and realizing miniaturization.
在一种优选实施方式中,在胎儿流体通道和母体流体通道的重叠区域通过多孔膜隔开胎儿流体通道和母体流体通道。In a preferred embodiment, the fetal fluid channel and the maternal fluid channel are separated by a porous membrane in the overlapping region of the fetal fluid channel and the maternal fluid channel.
上述技术方案:将重叠区域的多孔膜作为胎儿流体通道与母体流体通道之间的母胎交换界面,实现了胎盘结构和功能的准确模拟。The above technical solution: the porous membrane in the overlapping area is used as the maternal-fetal exchange interface between the fetal fluid channel and the maternal fluid channel, thereby realizing the accurate simulation of the placental structure and function.
在一种优选实施方式中,所述重叠区域的多孔膜大小可调节。In a preferred embodiment, the size of the porous membrane in the overlapping region can be adjusted.
上述技术方案:使得微流控芯片可用于模拟受限胎儿胎盘面积减小导致血流供应不足等病例。The above technical solution: the microfluidic chip can be used to simulate cases such as insufficient blood supply caused by the reduction of the restricted fetal placental area.
在一种优选实施方式中,全部或部分胎儿流体通道位于所述芯片本体的第一侧,母体流体通道位于所述芯片本体的第一侧。In a preferred embodiment, all or part of the fetal fluid channel is located on the first side of the chip body, and the maternal fluid channel is located on the first side of the chip body.
上述技术方案:胎儿流体通道与母体流体通道位于芯体本体同一侧,便于加工和实验操作,拥有同一平面的对照,能为当前双胞胎/多胞胎母胎屏障的研究及双胞胎/多胞胎特殊并发症的潜在病理生理机制研究提供代替模型。The above technical solution: the fetal fluid channel and the maternal fluid channel are located on the same side of the core body, which is convenient for processing and experimental operations, and has the same plane as the control, which can be used for the current research on the maternal-fetal barrier of twins/multiple births and special concomitant twins/multiple births. provide a surrogate model for the study of underlying pathophysiological mechanisms of the disease.
在一种优选实施方式中,在胎儿流体通道和母体流体通道的相邻区域通过多孔膜隔开胎儿流体通道和母体流体通道。In a preferred embodiment, the fetal fluid channel and the maternal fluid channel are separated by a porous membrane in adjacent regions of the fetal fluid channel and the maternal fluid channel.
上述技术方案:相邻区域的多孔膜作为胎儿流体通道与母体流体通道之间的母胎交换界面,实现了胎盘结构和功能的准确模拟。The above technical solution: the porous membrane in the adjacent area serves as the maternal-fetal exchange interface between the fetal fluid channel and the maternal fluid channel, realizing accurate simulation of placental structure and function.
在一种优选实施方式中,所述相邻区域的多孔膜大小可调节。In a preferred embodiment, the size of the porous membrane in the adjacent region can be adjusted.
上述技术方案:使得微流控芯片可用于模拟受限胎儿胎盘面积减小导致血流供应不足等病例。The above technical solution: the microfluidic chip can be used to simulate cases such as insufficient blood supply caused by the reduction of the restricted fetal placental area.
为了实现本发明的上述目的,根据本发明的第二个方面,本发明提供了一种多胎胎盘血管吻合模拟系统,包括本发明第一方面所述的微流控芯片和至少3个流体泵,利用多个流体泵分别为胎儿流体通道和母体流体通道泵入流体。In order to achieve the above object of the present invention, according to the second aspect of the present invention, the present invention provides a multiple-fetal placenta vascular anastomosis simulation system, including the microfluidic chip described in the first aspect of the present invention and at least 3 fluid pumps, A plurality of fluid pumps are used to pump fluid into the fetal fluid channel and the maternal fluid channel respectively.
上述技术方案:除了具备本发明第一方面提供的多胎胎盘血管吻合模型的微流控芯片的有益技术效果外,还具有通过流体泵实现流体泵入,便于操作、控制和实施的优点。The above technical solution: In addition to the beneficial technical effect of the microfluidic chip provided by the first aspect of the present invention, it also has the advantages of realizing fluid pumping through a fluid pump, which is convenient for operation, control and implementation.
在一种优选实施方式中,通过流体泵在第二连接通道的输入连接口泵入流体。In a preferred embodiment, the fluid is pumped into the input connection port of the second connection channel by a fluid pump.
上述技术方案:实现了向与第二连接通道连接的胎儿流体通道泵入任意的流速的流体信号,以便模拟各种血流动力不均衡病例。The technical solution above: realizes pumping fluid signals of any flow rate into the fetal fluid channel connected to the second connecting channel, so as to simulate various cases of hemodynamic imbalance.
为了实现本发明的上述目的,根据本发明的第三个方面,本发明提供了一种本发明第二方面所述的多胎胎盘血管吻合模拟系统的使用方法,包括:在重叠区域或相邻区域的多孔膜的第一侧面上附着第一种细胞,所述第一侧面为多孔膜朝向胎儿流体通道的侧面;在重叠区域或相邻区域的多孔膜的第二侧面上附着第二种细胞,所述第二侧面为多孔膜朝向母体流体通道的侧面;在细胞池内附着第三种细胞;设置连接通道的连接状态;将流体泵入胎儿流体通道和母体流体通道;对细胞池内第三种细胞和/或液体进行观察和/或检测。In order to achieve the above object of the present invention, according to the third aspect of the present invention, the present invention provides a method for using the multi-fetal placenta vascular anastomosis simulation system described in the second aspect of the present invention, including: The first type of cells is attached to the first side of the porous membrane of the porous membrane, and the first side is the side of the porous membrane facing the fetal fluid channel; the second type of cells is attached to the second side of the porous membrane in the overlapping area or the adjacent area, The second side is the side of the porous membrane facing the maternal fluid channel; attaching a third cell in the cell pool; setting the connection state of the connecting channel; pumping fluid into the fetal fluid channel and the maternal fluid channel; and/or liquids for observation and/or testing.
上述技术方案:能够为当前双胞胎/多胞胎母胎屏障的研究及双胞胎/多胞胎特殊并发症的潜在病理生理机制研究提供代替模型,便于研究实施。其中,将第一种细胞和第二种细胞附着在多孔膜两侧,因其自身的微孔结构,被用于很好模拟胎儿与母体之间的绒毛膜,提高模型研究的准确性。The technical solution above can provide a substitute model for the current research on the maternal-fetal barrier of twins/multiple births and the research on the potential pathophysiological mechanism of special complications of twins/multiple births, and is convenient for research and implementation. Among them, the first type of cells and the second type of cells are attached to both sides of the porous membrane. Because of its own microporous structure, it is used to simulate the chorion between the fetus and the mother to improve the accuracy of the model research.
在一种优选实施方式中,还包括:改变泵入胎儿流体通道和/或母体流体通道流体的流速;和/或,调节重叠区域或相邻区域的大小;和/或,调节泵入母体流体通道的流体的物质成分和/或物质成分比例。In a preferred embodiment, it also includes: changing the flow rate of the fluid pumped into the fetal fluid channel and/or the maternal fluid channel; and/or, adjusting the size of the overlapping area or adjacent area; and/or, adjusting the pumping of the maternal fluid The substance composition and/or the substance composition ratio of the fluid of the channel.
上述技术方案:实现多种病例的准确模拟研究。The above technical solution: realize accurate simulation research of various cases.
附图说明Description of drawings
图1是本发明实施例1中多胎胎盘血管吻合模型的微流控芯片的组成示意图;1 is a schematic diagram of the composition of the microfluidic chip of the multiple-fetal placental vascular anastomosis model in Example 1 of the present invention;
图2是本发明实施例1中多胎胎盘血管吻合模型的微流控芯片的第一层的一种结构示意图;Fig. 2 is a schematic structural view of the first layer of the microfluidic chip of the multiple-fetal placenta vascular anastomosis model in Example 1 of the present invention;
图3是本发明实施例1中多胎胎盘血管吻合模型的微流控芯片的第一层的另一种结构示意图;Fig. 3 is another schematic structural view of the first layer of the microfluidic chip of the multiple-fetal placenta vascular anastomosis model in Example 1 of the present invention;
图4是本发明实施例1中多胎胎盘血管吻合模型的微流控芯片的第二层的结构示意图;4 is a schematic structural diagram of the second layer of the microfluidic chip of the multiple-fetal placenta vascular anastomosis model in Example 1 of the present invention;
图5是本发明实施例1中多胎胎盘血管吻合模型的微流控芯片的重叠区域剖切示意图;Fig. 5 is a cross-sectional schematic diagram of the overlapping area of the microfluidic chip of the multiple-fetal placenta vascular anastomosis model in Example 1 of the present invention;
图6是本发明实施例2中多胎胎盘血管吻合模型的微流控芯片的一种结构示意图;Fig. 6 is a schematic structural view of a microfluidic chip of the multiple-fetal placenta vascular anastomosis model in Example 2 of the present invention;
图7是本发明实施例2中多胎胎盘血管吻合模型的微流控芯片的另一种结构示意图。Fig. 7 is another schematic structural view of the microfluidic chip of the multiple-fetal placenta vascular anastomosis model in Example 2 of the present invention.
附图标记:Reference signs:
1芯片本体;101第一层;102第二层;103母体流体通道;104胎儿流体通道;105第一连接通道;106第二连接通道;107细胞池;2多孔膜。1 chip body; 101 first layer; 102 second layer; 103 maternal fluid channel; 104 fetal fluid channel; 105 first connecting channel; 106 second connecting channel; 107 cell pool; 2 porous membrane.
具体实施方式Detailed ways
下面详细描述本发明的实施例,所述实施例的示例在附图中示出,其中自始至终相同或类似的标号表示相同或类似的元件或具有相同或类似功能的元件。下面通过参考附图描述的实施例是示例性的,仅用于解释本发明,而不能理解为对本发明的限制。Embodiments of the present invention are described in detail below, examples of which are shown in the drawings, wherein the same or similar reference numerals designate the same or similar elements or elements having the same or similar functions throughout. The embodiments described below by referring to the figures are exemplary only for explaining the present invention and should not be construed as limiting the present invention.
在本发明的描述中,需要理解的是,术语“纵向”、“横向”、“上”、“ 下 ”、“ 前 ”、“后 ”、“ 左 ”、“ 右 ”、“ 竖直”、“ 水平 ”、“顶 ”、“底 ”“ 内”、“外”等指示的方位或位置关系为基于附图所示的方位或位置关系,仅是为了便于描述本发明和简化描述,而不是指示或暗示所指的装置或元件必须具有特定的方位、以特定的方位构造和操作,因此不能理解为对本发明的限制。In describing the present invention, it should be understood that the terms "longitudinal", "transverse", "upper", "lower", "front", "rear", "left", "right", "vertical", The orientations or positional relationships indicated by "horizontal", "top", "bottom", "inner", "outer", etc. are based on the orientation or positional relationships shown in the drawings, and are only for the convenience of describing the present invention and simplifying the description, rather than Nothing indicating or implying that a referenced device or element must have a particular orientation, be constructed, and operate in a particular orientation should therefore not be construed as limiting the invention.
在本发明的描述中,除非另有规定和限定,需要说明的是,术语“安装”、“相连”、“连接”应做广义理解,例如,可以是机械连接或电连接,也可以是两个元件内部的连通,可以是直接相连,也可以通过中间媒介间接相连,对于本领域的普通技术人员而言,可以根据具体情况理解上述术语的具体含义。In the description of the present invention, unless otherwise specified and limited, it should be noted that the terms "installation", "connection" and "connection" should be understood in a broad sense, for example, it can be mechanical connection or electrical connection, or two The internal communication of each element may be directly connected or indirectly connected through an intermediary. Those skilled in the art can understand the specific meanings of the above terms according to specific situations.
实施例1Example 1
本实施例公开了一种多胎胎盘血管吻合模型的微流控芯片,如图1所示,包括芯片本体1,芯片本体1上设有母体流体通道103以及两个或两个以上的胎儿流体通道104,母体流体通道103与胎儿流体通道104之间设有多孔膜2,胎儿流体通道104之间设有可连通或断开的连接通道。This embodiment discloses a microfluidic chip for a multiple-fetal placental vascular anastomosis model, as shown in Figure 1, including a chip body 1, on which a maternal
在本实施例中,当具有两个胎儿流体通道104时用于模拟双胞胎胎盘血管吻合模型,当具有三个胎儿流体通道104时用于模拟三胞胎的胎盘血管吻合模型,依次类推模拟多胞胎胎盘血管吻合模型。In this embodiment, when there are two fetal
在本实施例中,多孔膜2优选但不限于为多孔聚碳酸酯膜、聚酯膜、聚四氯乙烯膜、弹性体膜(例如,聚二甲基硅氧烷、PDMS、聚氨酯或细胞外基质膜中的一种)。通过多孔膜2在胎儿流体通道104和母体流体通道103,尤其是两者的重叠区域或相邻区域实现流体连通与交换。多孔膜2在重叠区域和相邻区域形成半透屏障。第一层101和第二层102优选但不限于为采用聚二甲基硅氧烷PDMS)材料基板。In this embodiment, the
在本实施例中,芯片本体1至少包括两层,如图1中的第一层101和第二层102,将第一层101作为芯片本体1的第一侧,将第二层102作为芯片本体1的第二侧。将全部或部分胎儿流体通道104设于芯片本体1的第一侧,具体可位于第一层101内部或上表面或下表面。将母体流体通道103设于芯片本体1的第二侧,具体可位于第二层102内部或上表面或下表面,胎儿流体通道104和母体流体通道103在上下方向具有重叠区域。图5展示了重叠区域的剖面结构示意图,在图5中,母体流体通道103设于第二层102的上表面,胎儿流体通道104设于第一层101的下表面。In this embodiment, the chip body 1 includes at least two layers, such as the
在本实施例中,胎儿流体通道104的形状优选但不限于为L形或回字型或C形,优选地,多个胎儿流体通道104的形状一致,以便于更好地模拟实际情况。母体流体通道103的形状可设置为如图4所示的直线形,也可为其他形状,如“几”形、C形等。在胎儿流体通道104和母体流体通道103的两端均设置有连接口,可将一端的连接口作为入口,将另一端的连接口作为出口,入口可连接流体泵,出口可连接液体回收装置或其它容器。In this embodiment, the shape of the
在本实施例中,可在第一层101和第二层102之间设置多孔膜2,至少在胎儿流体通道104和母体流体通道103在上下方向的重叠区域设置多孔膜2,胎儿流体通道104和母体流体通道103通过多孔膜2隔开。In this embodiment, the
在本实施例中,多孔膜2的大小可大于重叠区域,比如与第一层101的下表面或第二层102的上表面大小相同。In this embodiment, the size of the
在本实施例中,进一步优选地,胎儿流体通道104和母体流体通道103在上下方向的重叠区域的多孔膜2的大小可调节。调节方式优选但不限于通过在原有重叠区域的多孔膜2上粘贴或涂覆一层不透的膜来减少重叠区域多孔膜2的大小,阻膜优选但不限于为塑料膜或油漆。调节方式还可为平移第一层101或第二层102以改变胎儿流体通道104和母体流体通道103的上下方向交叠区域的大小,进而改变重叠区域的多孔膜2的大小。In this embodiment, further preferably, the size of the
在本实施例中,连接通道包括使胎儿流体通道104间双向或多向互通的第一连接通道105。当微流控芯片用于模拟双胞胎胎盘血管吻合时,第一连接通道105可为图2和图3所示的双向通道,优选地,在该通道上设置第一阀门组件来控制该通道的连通或断开,第一阀门组件可为现有的手控阀门或电控阀门。当微流控芯片用于模拟三胞胎胎盘血管吻合时,第一连接通道105可为位于三个或三个以上胎儿流体通道104之间的多向互通通道,优选地,多向互通通道包括多个连接部和与多个连接部同时连接的汇聚部,多个连接部分别与多个胎儿流体通道104一一对应连接,优选地,在每个连接部设置一个第一阀门组件用于控制该连接部与胎儿流体通道104接通或断开,当所有连接部上的第一阀门组件开启时,所该连接部连接的胎儿流体通道104与其他胎儿流体通道104之间可以互通。In this embodiment, the connecting channel includes a first connecting
在本实施例中,第一层101的一种微流道结构示意图如图2所示,图2中两个胎儿流体通道104之间设有双向流通的第一连接通道105,以及两个单向的第二连接通道106,其中,一个第二连接通道106为右侧胎儿流体通道104流向左侧胎儿流体通道104,另一个第二连接通道106为左侧胎儿流体通道104流向右侧胎儿流体通道104。图2所示的结构充分模拟了实际双胞胎胎盘血管吻合中两个胎儿在胎盘浅表存在的动脉-动脉/静脉-静脉的双向血管吻合,与实际中两个胎儿之间的血液压力、流速不同导致存在相互之间的血流输送现象十分贴近。In this embodiment, a schematic diagram of a microchannel structure of the
在本实施例中,第一层101的另一种微流道结构示意图如图3所示,图3中是根据试验结果对图2所示的模型进行了改进,为便于更方便加工以及方便试验,将第二连接通道106设于其中一个胎儿流体通道104的侧部,此时,第二连接通道106的第一端与第二连接通道106连接的胎儿流体通道104连接,第二连接通道106的第二端设有输入连接口,通过在输入连接口设置一个流体泵向第二连接通道106泵入流体以模拟连接的胎儿流体通道104受另一个胎儿流体通道104输血等现象。In this embodiment, a schematic diagram of another microfluidic channel structure of the
在本实施例中,为观察胎儿之间的血流动力失衡对胎儿组织的影响,以及母体侧的变化对胎儿组织的影响,优选地,如图1、图2、图3所示,在胎儿流体通道104上设有细胞池107,细胞池用于附着胎儿组织细胞,组织细胞优选但不限于为胚胎干细胞或肝脏细胞或胰腺细胞或神经细胞。细胞池107的形状优选但不限于为椭圆形或圆形或方形。In this embodiment, in order to observe the influence of hemodynamic imbalance between fetuses on fetal tissues, and the influence of changes on the maternal side on fetal tissues, preferably, as shown in Figure 1, Figure 2, and Figure 3, the fetus
在本实施例中,优选地,在第一层101和第二层102之间还设置有中间层(中间层未图示),将第一层101的上表面作为芯片本体1的第一侧,在第一层101的上表面开设有胎儿流体通道104,将第二层102的上表面作为芯片本体1的第二侧,在第二层102的上表面设有母体流体通道103,在与胎儿流体通道104和母体流体通道103重叠区域对应的中间层部分开设有连接胎儿流体通道104和母体流体通道103的通孔,在通孔的两端覆有多孔膜2,通过两层多孔膜2将重叠区域的胎儿流体通道104和母体流体通道103隔开。In this embodiment, preferably, an intermediate layer (intermediate layer is not shown) is further provided between the
实施例2Example 2
本实施例提供了一种多胎胎盘血管吻合模型的微流控芯片,如图6和图7所示,微流控芯片包括芯片本体1,芯片本体1上设有母体流体通道103以及两个或两个以上的胎儿流体通道104,母体流体通道103与胎儿流体通道104之间设有多孔膜2,胎儿流体通道104之间设有可连通或断开的连接通道。连接通道包括使胎儿流体通道104间双向或多向互通的第一连接通道105,以及与胎儿流体通道104连接的仅允许流体单向流通的第二连接通道106。This embodiment provides a microfluidic chip for a multi-fetal placental vascular anastomosis model. As shown in Figures 6 and 7, the microfluidic chip includes a chip body 1, and the chip body 1 is provided with a maternal
本实施例与实施例1的区别在于:一是本实施例将全部或部分流体通道104与母体流体通道103设于芯片本体1的同一侧(如第一侧),如图6和图7所示;二是,位于芯片本体1同一侧的胎儿流体通道104和母体流体通道103的相邻区域通过多孔膜2隔开该侧的胎儿流体通道104和母体流体通道103,如图6和图7所示。The difference between this embodiment and Embodiment 1 is: First, this embodiment sets all or part of the
在本实施例中,芯片本体1优选但不限于为采用聚二甲基硅氧烷(PDMS)材料基板。在胎儿流体通道104和母体流体通道103的相邻区域,胎儿流体通道104和母体流体通道103互通,通过多孔膜2隔开。当胎儿流体通道104和母体流体通道103在相邻区域虽然距离较近但是不互通时,可开设通孔将两个微流道接通,在通孔两端设有多孔膜2进行流体和物质交换。In this embodiment, the chip body 1 is preferably, but not limited to, a polydimethylsiloxane (PDMS) material substrate. In the adjacent area of the
在本实施例中,相邻区域的多孔膜2大小可调节,可通过在相邻区域的多孔膜2上涂覆或粘贴阻膜实现。In this embodiment, the size of the
在本实施例中,胎儿流体通道104上设有细胞池107。每个胎儿流体通道104设置一个细胞池107。In this embodiment, the
在本实施例中,优选地,第一连接通道105上设有第一阀门组件,第二连接通道106上设有第二阀门组件。In this embodiment, preferably, the first connecting
在本实施例中,如图6所示,优选地,两个胎儿流体通道104之间设有一条或两条流通方向相反的第二连接通道106。进一步优选地,在每个第二连接通道106上设置一个第二阀门组件。In this embodiment, as shown in FIG. 6 , preferably, one or two second connecting
在本实施例中,如图7所示,优选地,第二连接通道106的第一端与胎儿流体通道104连接,第二连接通道106的第二端设有输入连接口。输入连接口与外设的一个流体泵连接,用于向与第二连接通道106连接的胎儿流体通道104泵入流体,以模拟胎儿之间的血液动力失衡现象。In this embodiment, as shown in FIG. 7 , preferably, the first end of the
在本发明提供的微流控芯片的第一种应用场景中,用于模拟单绒毛膜双羊膜囊双胎胎盘血管吻合,打开第一连接通道105和第二连接通道106,分别在胎儿流体通道104和母体流体通道103中泵入流体。第二连接通道106用于模拟胎盘深部相邻绒毛小叶存在单向血管吻合。第一连接通道105用于模拟胎盘浅表一般亦存在动脉-动脉/静脉-静脉双向血管吻合。第一阀门组件开启,两条方向相反第二连接通道106上的第二阀门组件开启,代表第一个胎儿脐血流的第一条胎儿流体通道104与代表第二个胎儿的脐血流的第二条胎儿流体通道104设定不同流速,使用脉冲式泵或非脉冲式泵泵入培养基,代表两胎儿的两条微通道之间产生流体压力差,促使血流通过吻合通道,模拟存在血管吻合的胎盘模型。In the first application scenario of the microfluidic chip provided by the present invention, it is used to simulate the vascular anastomosis of monochorionic diamniotic twin placenta, and the first connecting
在本发明提供的微流控芯片的第二种应用场景中,用于模拟双绒毛膜双羊膜囊双胎两胎儿胎盘血管吻合,胎盘多为两个,两胎儿胎盘无明显血管吻合,即使融合为一个胎盘,两胎儿的血流循环亦相对独立,关闭第一连接通道105和第二连接通道106,分别在胎儿流体通道104和母体流体通道103中泵入流体。关闭第一阀门组件和两条方向相反第二连接通道106上的第二阀门组件,代表第一个胎儿脐血流的第一条胎儿流体通道104与代表第二个胎儿脐血流的第二条胎儿流体通道104培养基流速一致,两胎儿血液循环相对独立,血流动力学相对稳定。In the second application scenario of the microfluidic chip provided by the present invention, it is used to simulate vascular anastomosis of two fetuses and placentas in dichorionic diamniotic sac twins. As a placenta, the blood circulation of the two fetuses is also relatively independent, the first connecting
实施例1和实施2提供的微流控芯片,可模拟存在血管吻合的模型和各部分(胎儿)相对独立循环的模型。能够用于研究双胞胎胎盘特殊结构下的潜在病理生理机制。The microfluidic chip provided in Example 1 and
实施例3本实施例公开了一种多胎胎盘血管吻合模拟系统,包括实施例1或实施例2提供的微流控芯片和至少3个流体泵,利用多个流体泵分别为胎儿流体通道104和母体流体通道103泵入流体。Embodiment 3 This embodiment discloses a multiple-fetal placental vascular anastomosis simulation system, including the microfluidic chip provided in Embodiment 1 or
在本实施例中,优选地,通过单独设置的流体泵在第二连接通道106的输入连接口泵入流体。该流体泵非胎儿流体通道104和母体流体通道103的流体泵,为单独另设的流体泵。In this embodiment, preferably, fluid is pumped into the input connection port of the
在本实施例中,流体泵分别与胎儿流体通道104、母体流体通道103、第二连接通道106的输入连接口连接向通道泵入流体。流体泵优选但不限于采用型号为WH-BCSP-22的双向连续注射泵,泵的输出口与流体通道的入口连接,泵的输入口与流体通道的出口连接,实现流体循环。In this embodiment, the fluid pumps are respectively connected to the input connection ports of the
实施例4Example 4
本实施例公开了一种实施例3提供的多胎胎盘血管吻合模拟系统的使用方法,包括:This embodiment discloses a method for using the multifetal placenta vascular anastomosis simulation system provided in Embodiment 3, including:
步骤A,在重叠区域或相邻区域的多孔膜2的第一侧面上附着第一种细胞,第一侧面为多孔膜朝向胎儿流体通道104的侧面。第一种细胞优选但不限于为胎儿毛细血管内皮的细胞,如脐静脉内皮细胞(“HUVEC”)、原代人胎盘绒毛内皮细胞(“HPVEC”)、从胎儿分离的原代人内皮细胞、源自胎儿的转化的人内皮细胞、干细胞衍生的内皮细胞。实施中,可用吸管等设备吸取包含第一种细胞的液体,将该液体输入胎儿流体通道104中(优选但不限于从胎儿流体通道104的入口输入),让其流过多孔膜2的第一侧面并静置,由于多孔膜2的多孔结构特点,第一种细胞会附着在多孔膜2的第一侧面上。Step A, attaching the first type of cells to the first side of the
步骤B,在重叠区域或相邻区域的多孔膜2的第二侧面上附着第二种细胞,第二侧面为多孔膜朝向母体流体通道103的侧面。第二种细胞代表滋养层细胞,优选但不限于绒毛膜(BeWo)细胞、BeWo b30克隆细胞、HTR8/SVneo滋养层细胞、绒毛膜癌(JEG3)细胞、原代人滋养层细胞、干细胞衍生的滋养层、转化的人滋养层细胞。在第一种细胞和第二种细胞中也可包括人工或自然诱导的病例,自然诱导的病理可以来自患病胎盘。同样地,将包含有第二种细胞的液体输入母体流体通道103,让液体流过多孔膜2的第二侧面并静置,由于多孔膜2的多孔结构特点,第二种细胞会附着在多孔膜2的第二侧面上。Step B, attaching the second type of cells on the second side of the
步骤C,在细胞池107内附着第三种细胞。第三种细胞为胎儿组织细胞,优选但不限于为胚胎干细胞、肝脏细胞、胰腺细胞、神经细胞。将包含有第三种细胞的液体输入细胞池107中并静置,为便于输入的第三种细胞很好地附着在细胞池107内,优选地,可将细胞池107设置于靠近胎儿流体通道104的出口,这样,从胎儿流体通道104的出口将液体输入细胞池107。Step C, attaching a third type of cells in the
步骤D,设置连接通道的连接状态。优选地,根据待模拟病例设置连接通道的连接状态,如在模拟双胞胎输血综合征时,将第一连接通道105关闭,第二连接通道106开启。如在模拟双胎动脉反向灌注综合征时,开启第一连接通道105和第二连接通道106。将流体泵入胎儿流体通道104和母体流体通道103;可通过流体泵泵入流体,流体优选但不限于为培养基。Step D, setting the connection state of the connection channel. Preferably, the connection state of the connection channel is set according to the case to be simulated, for example, when simulating twin-twin transfusion syndrome, the
步骤E,对细胞池107内第三种细胞和/或液体进行观察和/或检测。Step E, observe and/or detect the third cell and/or liquid in the
在本实施例中,优选地,改变泵入胎儿流体通道104和/或母体流体通道103流体的流速。可根据待模拟病例改变泵入胎儿流体通道104和/或母体流体通道103流体的流速,如在模拟双胎动脉反向灌注综合征时,一个胎儿流体通道104中流体的流速应大于另一个胎儿流体通道104中流体的流速。又如,在模拟妊娠期高血压时,加大母体流体通道103中流体的流速。In this embodiment, preferably, the flow rate of fluid pumped into the
在本实施例中,优选地,调节重叠区域或相邻区域的大小。可根据待模拟病例调节重叠区域或相邻区域的大小,如在模拟选择性宫内生长受限时,可减少重叠区域或相邻区域的多孔膜2的大小。In this embodiment, preferably, the size of the overlapping area or the adjacent area is adjusted. The size of the overlapping area or the adjacent area can be adjusted according to the case to be simulated. For example, when simulating selective intrauterine growth restriction, the size of the
在本实施例中,优选地,调节泵入母体流体通道103的流体的物质成分和/或物质成分比例,可根据待模拟病例调节泵入母体流体通道103的流体的物质成分和/或物质成分比例。物质成分优选但不限于为葡萄糖、脂肪酸、蛋白质、胆汁酸浓度。In this embodiment, preferably, the substance composition and/or substance composition ratio of the fluid pumped into the
在本发明提供的多胎胎盘血管吻合模拟系统的第一种应用场景中,用于模拟单绒毛膜双羊膜囊双胞胎特有并发症,第一连接通道105上的第一阀门组件,两个胎儿流体通道104之间设有两条单向的第二连接通道106,两条第二连接通道106的流体方向相反,每个第二连接通道106上设有第二阀门组件。具体有:In the first application scenario of the multiple-fetal placental vascular anastomosis simulation system provided by the present invention, it is used to simulate the unique complications of monochorionic diamniotic twins, the first valve assembly on the first connecting
1、双胞胎输血综合征(twin to twin transfusion syndrome, TTTs),第一阀门组件关闭,第一条单向吻合的第二连接通道106上的第二阀门组件开启,另一条方向相反的单向吻合的第二连接通道106上的第二阀门组件关闭,第一条胎儿流体通道104的流速设定大于第二条胎儿流体通道104,单位时间内培养基由第一条胎儿流体通道104代表的第一个胎儿(供血儿)向第二条胎儿流体通道104代表的第二个胎儿(受血儿)流动,两胎儿血流动力学不平衡。1. Twin to twin transfusion syndrome (TTTs), the first valve assembly is closed, the second valve assembly on the second connecting
2、双胎动脉反向灌注综合征(twin reversed arterial perfusion sequence,TRAPs), 双向吻合通道第一连接通道105上的第一阀门组件开启,第一条单向吻合的第二连接通道106上的第二阀门组件开启,另一条方向相反的单向吻合的第二连接通道106上的第二阀门组件开启,代表第一个胎儿的第一条胎儿流体通道104培养基流速不变,代表第二个胎儿的第二条胎儿流体通道104的入口和出口直接吻合,不外接流体泵,由代表第一个胎儿的流体泵带动代表两个胎儿的两条微流体通道的血流循环,两胎儿血流动力学不平衡。2. Twin reversed arterial perfusion sequence (TRAPs), the first valve assembly on the first connecting
3、选择性宫内生长受限(selective intrauterine growthrestriction,sIUGR),在模拟非复杂性双胞胎胎盘生理结构基础上,第一阀门组件关闭,第一条第二连接通道的第二阀门组件开启,第二条第二连接通道的第二阀门组件关闭,单位时间内培养基由第一条胎儿流体通道104代表的第一个胎儿(非受限胎儿)向第二条胎儿流体通道104道代表的第二个胎儿(受限胎儿)流动,并且减小代表第二个胎儿(受限胎儿)的微通道与代表母体面的母体流体通道103重叠区域的面积(可更改受限胎儿侧膜的半透面积或微通道宽度)模拟受限胎儿胎盘面积减小导致血流供应不足,两胎儿血流动力学不平衡。3. Selective intrauterine growth restriction (sIUGR), on the basis of simulating the physiological structure of uncomplicated twin placenta, the first valve component is closed, the second valve component of the first second connecting channel is opened, and the second valve component is opened. The second valve assemblies of the two second connecting channels are closed, and the culture medium is transferred from the first fetus (unrestricted fetus) represented by the first
4、双胎一胎宫内死亡(single intrauterine fetal death,sIUFD),在模拟非复杂性双胞胎胎盘生理结构基础上,第一条第二连接通道的第二阀门组件开启,第二条第二连接通道的第二阀门组件开启,代表第一个胎儿的第一条胎儿流体通道104培养基流速度不变,代表第二个胎儿的第二条胎儿流体通道104关闭流体泵,停止血流循环,两胎儿血流动力学不平衡。4. For single intrauterine fetal death (sIUFD), on the basis of simulating the physiological structure of uncomplicated twin placenta, the second valve component of the first second connection channel is opened, and the second second connection channel is opened. The second valve assembly of the channel is opened, the medium flow rate of the first
在本发明提供的多胎胎盘血管吻合模拟系统的第一种应用场景中,用于模拟在双胞胎妊娠时妊娠期并发症,具体有:In the first application scenario of the multi-fetal placental vascular anastomosis simulation system provided by the present invention, it is used to simulate pregnancy complications during twin pregnancy, specifically:
1、母体高血糖(Maternal hyperglycemia):在模拟非复杂性双胞胎胎盘生理结构基础上,增加代表母体的母体流体通道103泵入的培养基内葡萄糖浓度。1. Maternal hyperglycemia: On the basis of simulating the physiological structure of uncomplicated twin placenta, increase the glucose concentration in the culture medium pumped by the maternal
2、母体高血脂(Maternal hyperlipidemia):在模拟非复杂性双胞胎胎盘生理结构基础上,增加代表母体的母体流体通道103泵入的培养基内脂肪酸浓度。2. Maternal hyperlipidemia: On the basis of simulating the physiological structure of uncomplicated twin placenta, increase the concentration of fatty acids in the medium pumped by the maternal
3.母体营养不足(Maternal nutrition deficiency):在模拟非复杂性双胞胎胎盘生理结构基础上,减少代表母体的母体流体通道103泵入的培养基内容葡萄糖、脂肪酸、蛋白质等营养浓度。3. Maternal nutrition deficiency: On the basis of simulating the physiological structure of uncomplicated twin placenta, reduce the concentration of glucose, fatty acid, protein and other nutrients in the culture medium pumped by the maternal
4、妊娠期高血压(Hypertension during pregnancy):在模拟非复杂性双胞胎胎盘生理结构基础上,增加代表母体的母体流体通道103泵入的流体流速,减小微通道的宽度,可模拟胎盘血管痉挛,血压增高。4. Hypertension during pregnancy (Hypertension during pregnancy): On the basis of simulating the physiological structure of uncomplicated twin placenta, increase the fluid flow rate pumped into the maternal
5、妊娠期肝内胆汁淤积症(intrahepatic cholestasis of pregnancy):在模拟非复杂性双胞胎胎盘生理结构基础上,增加代表母体的母体流体通道103泵入的培养基内胆汁酸浓度。5. Intrahepatic cholestasis of pregnancy (intrahepatic cholestasis of pregnancy): On the basis of simulating the physiological structure of uncomplicated twin placenta, increase the bile acid concentration in the medium pumped by the maternal
在本发明提供的多胎胎盘血管吻合模拟系统的第一种应用场景中,用于评估治疗效果,在模拟双胞胎输血综合征(twin to twin transfusion syndrome, TTTs)后,通过选择性激光电凝治疗TTTs后,在关闭第一阀门组件和所有第二阀门组件,观察变化。In the first application scenario of the multifetal placental vascular anastomosis simulation system provided by the present invention, it is used to evaluate the treatment effect, after simulating twin to twin transfusion syndrome (TTTs), TTTs are treated by selective laser electrocoagulation After closing the first valve assembly and all second valve assemblies, observe the change.
本发明制备的双胞胎胎盘血管吻合模型的微流控芯片可以利用各种微工程技术来重构双胞胎胎盘屏障的三维微结构,动态微环境和生物功能的微工程细胞培养平台,扩展细胞培养模型的范围;并且可模拟两种不同绒毛膜性双胞胎胎盘的微结构,拥有同一平面的对照,能为当前双胞胎母胎屏障的研究及双胞胎特殊并发症的潜在病理生理机制研究提供代替模型。本微流控芯片可允许代表同一母体的两个胎儿的两种循环在同一模型上培养以模拟双胞胎同一母体宫内环境,允许两种类型的多胎胎盘血管吻合在同一装置中培养以形成对照;本微流控芯片可以模拟生理流动条件以实现双胞胎两胎儿与母体的血液对流运动,同一模型中的两胎儿之间的血液对流和/或单向流动;可以改变流动条件以模拟绒毛间隙和胎儿毛细血管的异常血液流动环境及施予治疗措施前后的变化;微流控芯片增加了代表胎儿组织的细胞池部分,将胎儿部分组织代谢与母胎屏障动态变化联系,进一步模拟母胎病理生理状态。The microfluidic chip of the twin placental vascular anastomosis model prepared by the present invention can use various micro-engineering techniques to reconstruct the three-dimensional microstructure of the twin placenta barrier, a micro-engineering cell culture platform for dynamic microenvironment and biological functions, and expand the capabilities of the cell culture model. range; and can simulate the microstructure of two different chorionic twin placenta, with the same plane of control, can provide a substitute model for the current study of twin maternal-fetal barrier and the potential pathophysiological mechanism of twin special complications. This microfluidic chip can allow the two circulations of two fetuses representing the same mother to be cultured on the same model to simulate the intrauterine environment of twins, and allow two types of multiple placental vascular anastomoses to be cultured in the same device to form a control; The microfluidic chip can simulate physiological flow conditions to realize convective blood movement between twin fetuses and the mother, blood convection and/or unidirectional flow between two fetuses in the same model; flow conditions can be changed to simulate the gap between villi and fetus The abnormal blood flow environment of capillaries and the changes before and after treatment; the microfluidic chip adds a cell pool representing fetal tissue, and links the metabolism of fetal tissue with the dynamic change of the maternal-fetal barrier to further simulate the pathophysiological state of the mother-fetal.
在本说明书的描述中,参考术语“一个实施例”、“一些实施例”、“示例”、“具体示例”、或“一些示例”等的描述意指结合该实施例或示例描述的具体特征、结构、材料或者特点包含于本发明的至少一个实施例或示例中。在本说明书中,对上述术语的示意性表述不一定指的是相同的实施例或示例。而且,描述的具体特征、结构、材料或者特点可以在任何的一个或多个实施例或示例中以合适的方式结合。In the description of this specification, descriptions referring to the terms "one embodiment", "some embodiments", "example", "specific examples", or "some examples" mean that specific features described in connection with the embodiment or example , structure, material or characteristic is included in at least one embodiment or example of the present invention. In this specification, schematic representations of the above terms do not necessarily refer to the same embodiment or example. Furthermore, the specific features, structures, materials or characteristics described may be combined in any suitable manner in any one or more embodiments or examples.
尽管已经示出和描述了本发明的实施例,本领域的普通技术人员可以理解:在不脱离本发明的原理和宗旨的情况下可以对这些实施例进行多种变化、修改、替换和变型,本发明的范围由权利要求及其等同物限定。Although the embodiments of the present invention have been shown and described, those skilled in the art can understand that various changes, modifications, substitutions and modifications can be made to these embodiments without departing from the principle and spirit of the present invention. The scope of the invention is defined by the claims and their equivalents.
Claims (11)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210134472.0A CN114437932B (en) | 2022-02-14 | 2022-02-14 | Microfluidic chip, system and using method of multi-placenta vascular anastomosis model |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210134472.0A CN114437932B (en) | 2022-02-14 | 2022-02-14 | Microfluidic chip, system and using method of multi-placenta vascular anastomosis model |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114437932A CN114437932A (en) | 2022-05-06 |
CN114437932B true CN114437932B (en) | 2023-06-30 |
Family
ID=81373790
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210134472.0A Active CN114437932B (en) | 2022-02-14 | 2022-02-14 | Microfluidic chip, system and using method of multi-placenta vascular anastomosis model |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114437932B (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN208844105U (en) * | 2018-08-01 | 2019-05-10 | 力因精准医疗产品(上海)有限公司 | A kind of micro flow control chip device for Embryo Culture |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3574985A1 (en) * | 2013-12-20 | 2019-12-04 | President And Fellows Of Harvard College | Organomimetic devices and methods of use and manufacturing thereof |
GB2588733A (en) * | 2015-03-24 | 2021-05-05 | Univ Pennsylvania | Artificial placenta |
KR101985311B1 (en) * | 2017-07-26 | 2019-06-03 | 강원대학교산학협력단 | 3 Dimensional Cell Culture Microchip Containing Nano-porous Membrane And Manufacturing Method Thereof |
CN108443579B (en) * | 2018-04-11 | 2020-06-26 | 利多(香港)有限公司 | A microvalve and microfluidic chip capable of controlling liquid flow |
CN110551681B (en) * | 2019-09-12 | 2021-08-24 | 清华大学 | Microfluidic chip for simulating embryo implantation angiogenesis and preparation method and use thereof |
CN111235029B (en) * | 2020-03-09 | 2023-01-31 | 辽宁中医药大学 | Multifunctional microfluidic chip and preparation method and application thereof |
CN112300940B (en) * | 2020-10-30 | 2023-06-16 | 大连医科大学 | Periodontal soft tissue bionic chip constructed based on microfluidic technology and application thereof |
CN112280678B (en) * | 2020-12-25 | 2021-04-06 | 苏州大学 | Detachable and reusable hydrophobic or super-hydrophobic microfluidic organ chip |
CN113106020A (en) * | 2021-04-02 | 2021-07-13 | 中山大学 | Micro-fluidic chip and method for establishing human colorectal cancer dynamic model |
CN114045218A (en) * | 2021-10-21 | 2022-02-15 | 中国科学院大连化学物理研究所 | Heart/liver/placenta/brain/pancreatic island multi-organ chip |
-
2022
- 2022-02-14 CN CN202210134472.0A patent/CN114437932B/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN208844105U (en) * | 2018-08-01 | 2019-05-10 | 力因精准医疗产品(上海)有限公司 | A kind of micro flow control chip device for Embryo Culture |
Also Published As
Publication number | Publication date |
---|---|
CN114437932A (en) | 2022-05-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR102530274B1 (en) | Vascularized in vitro perfusion device, manufacturing method and application method thereof | |
CN111218404A (en) | A bionic multi-organ chip and its preparation method and application | |
CN103981096B (en) | Two-layer cell culture system organ chip and preparation method thereof | |
Sato et al. | Recent progress in the development of microfluidic vascular models | |
CN111819442A (en) | Bioreactor Screening Platform for Simulating Human Systems Biology and Screening for Inotropic Effects of Agents on the Heart | |
BR112015006859B1 (en) | multi-organ device on chip | |
WO2022104626A1 (en) | Micro-fluidic technology-based multifunctional organ chip, preparation method therefor and use thereof | |
CN106811413A (en) | Multiple organ chip based on microflow control technique and preparation method thereof | |
CN103981085B (en) | A kind of from establishing concentration gradient drug screening organ chip and preparation method thereof | |
CN110551679B (en) | A method for precise printing and construction of a liver unit chip with acinar three-vessel structure | |
CN108485975A (en) | Bionical chip kidney | |
Palaninathan et al. | Multi-organ on a chip for personalized precision medicine | |
KR102737989B1 (en) | Systems and methods for multilane vascular structures | |
CN109517737A (en) | A kind of micro-fluidic chip and metastasis models and model building method and application based on the chip | |
CN114437932B (en) | Microfluidic chip, system and using method of multi-placenta vascular anastomosis model | |
CN220317827U (en) | Uterine spiral artery remodeling model chip based on microfluidic technology | |
CN107955787A (en) | A kind of construction method of the bionical intestines model based on microflow control technique | |
CN113528334A (en) | Microfluidic experimental plate and cell culture method | |
CN117721019A (en) | Vascularized organ chip and application thereof | |
CN115895895A (en) | Blood vessel series-connected multi-organ chip model and application method thereof | |
CN220317828U (en) | Parallel organoid chip system for evaluating placenta-peripheral organ adaptation of pregnant women | |
CN114854588A (en) | Barrier-stem cell homing bionic micro-fluidic chip and application thereof | |
CN210683803U (en) | Three-vessel liver lobule chip | |
CN220413410U (en) | Series-connected organoid chip system for evaluating preeclampsia multi-organ damage | |
CN208472114U (en) | Bionical chip kidney |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |